TABLE 2.
Average leucine uptake rates measured in the dark in the Atlantic experiments after two preconditioning treatments
| Cruise | Preconditioning treatment
|
Dark:light ratioa (%) | |
|---|---|---|---|
| In situ-simulated PAR (pmol Leu liter−1 h−1) | Dark (pmol Leu liter−1 h−1) | ||
| Incocéano-1 | 19.4 | 31.5 | 162** |
| 15.7 | 20.6 | 131** | |
| 30.2 | 117.6 | 389 | |
| 20.8 | 52.7 | 253*** | |
| 9.5 | 13.6 | 143 | |
| 35.4 | 104.0 | 294** | |
| 48.2 | 90.4 | 188** | |
| 154.7 | 280.8 | 181** | |
| 15.1 | 45.7 | 304** | |
| Mean ± SE | 38.8 ± 15.0 | 84.1 ± 27.5 | 227 ± 29 |
| Incocéano-2 | 27.8 | 13.6 | 49 |
| 27.1 | 21.2 | 78 | |
| 48.6 | 51.5 | 106 | |
| 262.9 | 731.5 | 278*** | |
| 1464.6 | 1112.2 | 76** | |
| 401.2 | 338.0 | 84 | |
| 10.2 | 25.3 | 247 | |
| 32.0 | 47.2 | 147* | |
| 44.6 | 62.6 | 140* | |
| 164.1 | 109.0 | 66 | |
| 51.7 | 35.2 | 68 | |
| Mean ± SE | 230.4 ± 128.9 | 231.6 ± 109.5 | 122 ± 23 |
The average ratio of the value in dark bottle to that in the light bottle (expressed as a percentage) is given, with an indication of significant differences between in situ and dark data (t test) as follows: *, P < 0.05; **, P < 0.01; ***, P < 0.001.